| Patiromer Sorbitex Calcium | Relypsa Inc | ||
| 8.4, 16.8, 25.2 gm, Base/ Packet, Powder, Oral |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
|
More Than 5
|
None | ||
| None | None | ||
| Veltassa is indicated for the treatment of hyperkalemia (high levels of potassium in your blood) | |||
|
Yes
| |||
| Veltassa | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ***** | *** ********* | ******* | *** ********* | *** ********* | *** ********* | ******* | *** ********* | *** ********* | *** ********* | ******* | ******* | *** ********* | ******* |
| ****** ****** | *** ********* | ******* | *** ********* | *** ********* | *** ********* | ******* | *** ********* | *** ********* | *** ********* | ******* | ******* | *** ********* | ******* |
| *** ******* ******** *** **** ******* | *********-******* ****** *** ******** ************ *** ************ | *** ******* ******** *** **** ******* | ******* *** ************ *** ********* ** *** ********** | *** ******* ******** *** **** ******* | *** ******* ******** *** **** ******* | *** ******* ******** *** **** ******* | ****** ****** ********** ****************** ************ | *** ******* ******** *** **** ******* | *** ******* ******** *** **** ******* | *** ******* ******** *** **** ******* | *********-******* ****** *** ******** ************ *** ************ | *********-******* ****** *** ******** ************ *** ************ |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ***** | *** \ ********* | *** **, **** | ******* | **** | ***** *** **** (***** ******) |
| ****** ****** | *** \ ********* | *** **, **** | ******* | **** | ***** *** **** (***** ******) |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|